Used in neuroscience and pharmaceutical research to quantify levels of phosphodiesterase 10A (PDE10A) in mouse tissue samples, particularly in studies related to brain function and psychiatric disorders. Enables researchers to assess PDE10A expression in conditions such as schizophrenia, Huntington's disease, and other neurological disorders where cAMP and cGMP signaling pathways are involved. Supports high-throughput screening of drug candidates targeting PDE10A activity. Commonly applied in preclinical studies using mouse models to evaluate therapeutic interventions and understand enzyme regulation in different brain regions.